文章摘要
崔晗 宦梦蕾 宋彦峰 刘道洲 叶威良 张邦乐 王玉琨 周四元.线粒体靶向TPP-DOX连接物的制备及其 逆转肿瘤耐药活性研究[J].,2015,15(9):1619-1622
线粒体靶向TPP-DOX连接物的制备及其 逆转肿瘤耐药活性研究
Preparation of Mitochondrial Targeting TPP-DOX Conjugate to Overcomingthe Drug Resistance of Doxorubicin
  
DOI:
中文关键词: (3- 丙羧基)三苯基溴化膦  阿霉素  线粒体  多药耐药
英文关键词: (3-Carboxypropyl)Triphenylphosphonium  Doxorubicin  Mitochondria  Multi-drug resistance
基金项目:国家自然科学基金项目(81301303)
作者单位
崔晗 宦梦蕾 宋彦峰 刘道洲 叶威良 张邦乐 王玉琨 周四元 第四军医大学药学院药剂学教研室第四军医大学药学院药事管理与药物信息学教研室 
摘要点击次数: 741
全文下载次数: 3039
中文摘要:
      目的:阿霉素(DOX)是常用的抗肿瘤药物,但是它的毒副作用大,而且肿瘤细胞易对DOX 产生耐药,限制了其临床应用。本 研究利用肿瘤细胞线粒体跨膜电位较高的特性,将亲脂性阳离子(3-丙羧基)三苯基溴化膦(TPP)与DOX相连接制备具有线粒体 靶向功能的TPP-DOX,以期达到逆转肿瘤细胞耐药的目的。方法:以DOX、TPP为原料,合成TPP-DOX,通过核磁、质谱等方法进 行结构鉴定。采用MTT 方法研究TPP-DOX对KB 细胞、A549 细胞及耐DOX 肿瘤细胞MDA-MB-231/ADR的体外抗肿瘤活性。 采用激光共聚焦显微镜观察TPP-DOX 在肿瘤细胞内的分布。结果:TPP-DOX 对KB 细胞和A549 细胞的毒性低于DOX, TPP-DOX 对耐DOX 肿瘤细胞MDA-MB-231/ADR 的毒性明显大于DOX。激光共聚焦显示TPP-DOX 分布于细胞核和线粒体 中。结论:TPP-DOX 具有线粒体靶向特性,可有效逆转肿瘤耐药,有进一步研究的价值。
英文摘要:
      Objective:Doxorubicin (DOX) is a commonly used chemotherapy drug for tumor treatment. However, the severe side effects and multiple drug resistance (MDR) hinder its clinical application. The mitochondrial trans-membrane potential is relative high, thus lipophilic cations show high affinity with mitochondria. In this paper, (3-carboxyl) phenyl bromide phosphine (TPP) was conjugated with DOX to prepare mitochondria targeting TPP-DOX to overcome drug resistance of tumor cells.Methods:TPP-DOX was synthesized by connecting TPP and DOX. The structure of TPP-DOX was confirmed by 1HNMR and MS. The antitumor activity of TPP-DOX was tested in vitro against KB cells, A549 cells and MDA-MB-231/ADR cells by MTT method. The laser confocal microscope was used to observe the cellular uptake and distribution of the TPP-DOX in tumor cells.Results:TPP-DOX exhibited lower cytotoxicity than free DOX on KB cells and A549 cells, but it showed higher cytotoxicity than free DOX on MDA-MB-231/ADR cells. Confocal microscopy confirmed that TPP-DOX distributed in the mitochondria and nucleus.Conclusion:TPP-DOX can overcome drug resistance in tumor cells, and it is worthy of further investigation.
查看全文   查看/发表评论  下载PDF阅读器
关闭